Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

Santos, Filipa, Cabreira, Verónica, Rocha, Sara, Massano, João · 2023 · Journal of Geriatric Psychiatry and Neurology

Abstract

Importance Accurately diagnosing neurodegenerative dementia is often challenging due to overlapping clinical features. Disease specific biomarkers could enhance diagnostic accuracy. However, CSF analysis procedures and advanced imaging modalities are either invasive or high-priced, and routinely unavailable. Easily accessible disease biomarkers would be of utmost value for accurate differential diagnosis of dementia subtypes. Objective To assess the diagnostic accuracy of blood-based biomarkers for the differential diagnosis of AD from Frontotemporal Lobar Degeneration (FTLD), or AD from Dementia with Lewy Bodies (DLB). Methods Systematic review. Three databases (PubMed, Scopus, and Web of Science) were searched. Studies assessing blood-based biomarkers levels in AD versus FTLD, or AD versus DLB, and its diagnostic accuracy, were selected. When the same biomarker was assessed in three or more studies, a meta-analysis was performed. QUADAS-2 criteria were used for quality assessment. Results Twenty studies were included in this analysis. Collectively, 905 AD patients were compared to 1262 FTLD patients, and 209 AD patients were compared to 246 DLB patients. Regarding biomarkers for AD versus FTLD, excellent discriminative accuracy (AUC >0.9) was found for p-tau181, p-tau217, synaptophysin, synaptopodin, GAP43 and calmodulin. Other biomarkers also demonstrated good accuracy (AUC = 0.8-0.9). For AD versus DLB distinction, only miR-21-5p and miR-451a achieved excellent accuracy (…

Overview

Integrity signals

Registry

Crossref · 10.1177/08919887221141651

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 141 references

Research works printed but not linked: 5

  1. Finger EC, 2016, Continuum, 22, 464
  2. Gomperts SN, 2016, Continuum (Minneap Minn), 22, 435
  3. Higgins JPT LT, 2022, Cochrane Handbook for Systematic Reviews of Interventions version 63
  4. Ritchie C, 2017, Cochrane Database Syst Rev, 3, Cd010803
  5. Kasuga K, 2012, Int J Alzheimers Dis, 2012, 437025

Cited by

See all 25

Metadata

Authors
Santos, F., Cabreira, V., Rocha, S., & Massano, J.
Affiliations
Universidade do Porto (PT)
Corresponding author
Massano, João
Venue
Journal of Geriatric Psychiatry and Neurology
Published
2022-11-24
Volume
36
Issue
4
Pages
267-281
ISSN
  • 0891-9887 (ISSN-L)
  • 1552-5708
OpenAlex
W4309889932
Cited by
24
References
141
Citations by year
2026: 5 · 2025: 12 · 2024: 5 · 2023: 2
FWCI
0.81
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Geriatric Psychiatry and Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
blood biomarkers, neurodegenerative dementia, Alzheimer's disease, frontotemporal lobar degeneration, dementia with Lewy bodies, differential diagnosis, diagnostic accuracy, phosphorylated tau, synaptophysin, synaptopodin, GAP-43, calmodulin, microRNA, miR-21-5p, miR-451a
MeSH terms
Alzheimer Disease, Diagnosis, Differential, Humans, Prospective Studies, Biomarkers, Amyloid beta-Peptides, tau Proteins, Lewy Body Disease, MicroRNAs, Frontotemporal Lobar Degeneration, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review. https://app.cochat.ai/papers/10.1177/08919887221141651
The paper
Santos, F., Cabreira, V., Rocha, S., & Massano, J. (2023). Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/08919887221141651

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.